The Human Pleiotropic Map of GWAS Associations and Therapeutic Implications
This study systematically analyzes over 100,000 GWAS to demonstrate that while protein-altering variant support strongly predicts therapeutic success, combining this evidence with intermediate levels of gene pleiotropy (affecting 2–5 traits) optimizes drug discovery by balancing efficacy with organism-level safety, thereby identifying a high-probability profile already validated by numerous approved therapies.